
Nutrition Diva The revolution in diabetes care that no-one is talking about
4 snips
Nov 20, 2024 GLP-1 receptor agonists are changing the way we approach obesity and diabetes management. Originally intended for different purposes, these medications now offer benefits like weight loss and improved cardiovascular health. Discover the promising dual-action medication terzepatide, which targets both GLP-1 and GIP receptors for enhanced glucose control. The podcast highlights the obstacles patients face in accessing these innovative therapies and emphasizes the importance of greater public awareness about diabetes.
Chapters
Transcript
Episode notes
